Atlas Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
+400
New +$192K 0.22% 63
2026
Q1
Sell
-400
Closed -$232K 67
2025
Q4
$232K Sell
400
-25
-6% -$14.1K 0.26% 56
2025
Q3
$206K Buy
+425
New +$198K 0.21% 61
2025
Q2
Sell
-425
Closed -$212K 55
2025
Q1
$212K Hold
425
0.26% 51
2024
Q4
$221K Hold
425
0.28% 47
2024
Q3
$263K Buy
+425
New +$252K 0.4% 39
2023
Q3
Sell
-425
Closed -$239K 39
2023
Q2
$239K Buy
+425
New +$229K 0.69% 32

Other funds holding TMO

Atlas Wealth Partners's TMO Position: Q2 2026 in Review

Atlas Wealth Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 400 shares worth $201K. The stake represents 0.22% of the portfolio and ranks #63 among its holdings. This is a return to the name: Atlas Wealth Partners previously reported a position in TMO as recently as Q4 2025.

Atlas Wealth Partners first reported a position in TMO in Q2 2023 and has held it in 7 quarters since. The position peaked at $263K in Q3 2024. 1,184 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Atlas Wealth Partners held 400 shares of Thermo Fisher Scientific worth $201K as of Q2 2026.
  • Thermo Fisher Scientific was a new Atlas Wealth Partners position in Q2 2026.
  • Thermo Fisher Scientific made up 0.22% of Atlas Wealth Partners's portfolio in Q2 2026, its #63 holding.
  • Atlas Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 7 quarters since.
  • Atlas Wealth Partners's Thermo Fisher Scientific position peaked at $263K in Q3 2024.
  • 1,184 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Atlas Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.